Outcome of subtenon injection of triamcinolone acetonide in eyes of age-related macular degeneration with good visual acuity Maki Takahashi 1 , Taku Sato 1 , Yasushi Horiuchi 1 , Goro Watanabe 1 , Masahiro Morimoto 1 , Hidetaka Matsumoto 1 , Satomi Noda 1 , Michiko Tokukura 1 , Shoji Kishi 1 1Dept of Ophthalmol, Gunma Univ Sch of Med pp.779-784
Published Date 2007/5/15
DOI https://doi.org/10.11477/mf.1410101625
  • Abstract
  • Look Inside
  • Reference

Abstract. Purpose:To report the outcome of subtenon injection of triamcinolone acetonide(TA)for age-related macular degeneration(AMD)with good visual acuity. Cases and Method:This study was made on 31 eyes of exudative AMD with corrected visual acuity of 0.6 or better. Each eye received 20 or 40mg of TA as subtenon injection. All cases were followed up for 6 months or longer. According to Kaplan-Meier method, cases were defined as dead when the visual acuity decreased to 0.5 or lower or when photodynamic therapy(PDT)was performed. Results:Fifteen eyes(48%)were alive one year after treatment. Serous retinal detachment disappeared in 17 eyes(55%). PDT had to be performed on 10 eyes after an average of 6.4 months of TA injection. There was no case of acute reduction of visual acuity after TA injection. Conclusion:Subtenon injection of TA is indicated as the initial treatment for AMD with good visual acuity.

Copyright © 2007, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院